1-(1-(3-(Cyclohexyloxy)benzyl)piperidin-4-yl)-5-methylpyrimidine-2,4(1H,3H)-dione

ID: ALA4864545

PubChem CID: 164624036

Max Phase: Preclinical

Molecular Formula: C23H31N3O3

Molecular Weight: 397.52

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cn(C2CCN(Cc3cccc(OC4CCCCC4)c3)CC2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C23H31N3O3/c1-17-15-26(23(28)24-22(17)27)19-10-12-25(13-11-19)16-18-6-5-9-21(14-18)29-20-7-3-2-4-8-20/h5-6,9,14-15,19-20H,2-4,7-8,10-13,16H2,1H3,(H,24,27,28)

Standard InChI Key:  LLKZVVMUQSSKDF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   13.7019  -19.7795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4103  -20.1870    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.1173  -19.7773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8259  -20.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5325  -19.7782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5317  -18.9602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8183  -18.5529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1147  -18.9642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2406  -20.1861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9479  -19.7767    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6553  -20.1898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3605  -19.7839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3638  -18.9664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6558  -18.5564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9445  -18.9639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0726  -18.5597    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7784  -18.9744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4851  -18.5712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4915  -17.7537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7851  -17.3410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0722  -17.7459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1901  -18.9844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2019  -17.3497    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.3659  -17.3349    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.7066  -18.9634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0023  -18.5560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2928  -18.9622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2921  -19.7804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0009  -20.1923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  5  9  1  0
  9 10  1  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  1  0
 16 21  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 18 22  1  0
 19 23  2  0
 21 24  2  0
  1 25  1  0
  1 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4864545

    ---

Associated Targets(Human)

MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

tmk Thymidylate kinase (360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 397.52Molecular Weight (Monoisotopic): 397.2365AlogP: 3.39#Rotatable Bonds: 5
Polar Surface Area: 67.33Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.32CX Basic pKa: 8.11CX LogP: 3.16CX LogD: 2.37
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.84Np Likeness Score: -0.73

References

1. Song L, Merceron R, Hulpia F, Lucía A, Gracia B, Jian Y, Risseeuw MDP, Verstraelen T, Cos P, Aínsa JA, Boshoff HI, Munier-Lehmann H, Savvides SN, Van Calenbergh S..  (2021)  Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors.,  225  [PMID:34450493] [10.1016/j.ejmech.2021.113784]

Source